6/9/2023  5:35:04 PM Chg. +1.00 Volume Bid5:35:04 PM Ask6/9/2023 Market Capitalization Dividend Y. P/E Ratio
106.80EUR +0.95% 130,466
Turnover: 14 mill.
-Bid Size: - -Ask Size: - 3.35 bill.EUR 1.17% 34.90

Business description

Gerresheimer is a leading global partner to the pharma and healthcare industry. With its specialty glass and plastic products, the company contributes to health and well-being. It has worldwide operations and about 10,000 employees manufacture the products in local markets, close to its customers. The comprehensive product portfolio includes pharmaceutical packaging and products for the safe, simple administration of medicines: Insulin pens, inhalers, prefillable syringes, injection vials, ampoules, bottles and containers for liquid and solid medicines with closure and safety systems as well as packaging for the cosmetics industry.
 

Management board & Supervisory board

CEO
Dietmar Siemssen
Management board
Dr. Bernd Metzner, Dr. Lukas Burkhardt
Supervisory board
Dr. Axel Herberg, Francesco Grioli, Andrea Abt, Dr. Karin Louise Dorrepaal, Dr. Peter Noé, Franz Hartinger, Katja Schnitzler, Markus Rocholz, Paul Schilling, Theodor Stuth, Udo J. Vetter, Robert Fröhler, Prof. Dr. Annete G. Köhler, Marlis Mergenthal
 

Company data

Name: Gerresheimer AG
Address: Klaus-Bungert-Straße 4,D-40468 Düsseldorf
Phone: +49-211-6181-00
Fax: +49-211-6181-295
E-mail: info@gerresheimer.com
Internet: www.gerresheimer.com
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 11/30
Free Float: 43.29%
IPO date: 6/11/2007

Investor relations

Name: Carolin Nadilo
IR phone: +49-211-6181-314
IR Fax: +49-211-6181-121
IR e-mail: carolin.nadilo@gerre...mer.com carolin.nadilo@gerresheimer.com

Company calendar

CW 24 | 6/12/2023 Dividend Payment
CW 27 | 7/6/2023 Interim Report 2nd Quarter/6 Months
CW 40 | 10/5/2023 Interim Report 3rd Quarter/9 Months